Adma Biologics reported $4.14B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 3.49B 853M Sep/2025
Alnylam Pharmaceuticals USD 59.77B 17.25B Sep/2025
Dynavax Technologies USD 1.16B 26M Sep/2025
Takeda JPY 7.64T 774.9B Dec/2025